Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
PODD logo

Insulet Revenues Surge 30.7% as Omnipod 5 Reaches 600,000 Users

PODD10-KFiling Date: 2/18/2026
Insulet Corporation
Description

What this story covers

Insulet Corporation’s 2025 10-K reveals a transformative year with 30.7% revenue growth and 71.6% gross margins. Driven by the Omnipod 5’s expansion into Type 2 diabetes and international markets, the company now serves over 600,000 active users globally.

Story snapshot

CompanyInsulet Corporation
TickerPODD
VariantStandard detailed
Duration13:34
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001145197-26-000028
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in